OW
Outlook Wealth Advisors, LLC
13F filer · CIK 0001767151Reported Aug 3, 2026
Net buyer this quarter
13F portfolio value$463MU.S. long equity reported on 13F
Positions16610 new · 10 closed
Net flow last quarter+$5MBuys minus sells
Top 10 positions weight14.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 3, 2026166 positions | |||||
| $17.9M | 3.86% | Not reported | -0.3% | Q4 2018 | |
| $14.7M | 3.18% | 0.00% | -0.5% | Q4 2019 | |
| $6.76M | 1.46% | 0.00% | -0.7% | Q4 2018 | |
| $4.64M | 1.00% | Not reported | +9.0% | Q4 2018 | |
| $4.19M | 0.90% | 0.00% | -6.8% | Q4 2018 | |
| $3.85M | 0.83% | 0.00% | -2.1% | Q4 2018 | |
| $3.81M | 0.82% | 0.00% | -1.9% | Q4 2018 | |
| $3.8M | 0.82% | 0.00% | -7.3% | Q4 2018 | |
| $3.5M | 0.76% | Not reported | +9.9% | Q4 2020 | |
| $3.24M | 0.70% | 0.00% | -0.3% | Q4 2018 | |
| OBONEZOne Bio, Corp. | $3.17M | 0.68% | Not reported | +340.7% | Q2 2025 |
| $2.92M | 0.63% | 0.05% | +28.6% | Q4 2025 | |
| $2.56M | 0.55% | 0.00% | -0.6% | Q4 2018 | |
| $2.44M | 0.53% | 0.00% | -5.6% | Q4 2018 | |
| $2.3M | 0.50% | 0.00% | +88.8% | Q1 2026 | |
| $1.84M | 0.40% | 0.00% | +0.9% | Q4 2019 | |
| $1.8M | 0.39% | 0.00% | -1.1% | Q4 2018 | |
| $1.79M | 0.39% | Not reported | +0.2% | Q4 2018 | |
| $1.75M | 0.38% | Not reported | -0.1% | Q4 2025 | |
| $1.74M | 0.38% | 0.03% | Not reported | Q1 2022 | |
| $1.63M | 0.35% | 0.22% | 0.0% | Q2 2020 | |
| $1.52M | 0.33% | 0.00% | -4.4% | Q3 2024 | |
| $1.48M | 0.32% | 0.00% | +38.3% | Q1 2021 | |
| $1.42M | 0.31% | 0.00% | +0.3% | Q3 2024 | |
| $1.39M | 0.30% | 0.00% | +15.7% | Q4 2019 | |
| $1.38M | 0.30% | 0.00% | -2.0% | Q4 2018 | |
| $1.38M | 0.30% | 0.00% | +80.9% | Q4 2023 | |
| $1.35M | 0.29% | 0.00% | -6.6% | Q1 2025 | |
| $1.33M | 0.29% | Not reported | +3.8% | Q4 2018 | |
| $1.26M | 0.27% | 0.00% | -0.6% | Q4 2018 | |
| $1.16M | 0.25% | Not reported | +0.5% | Q3 2024 | |
| $1.13M | 0.24% | 0.00% | -2.7% | Q2 2020 | |
| $1.12M | 0.24% | 0.00% | Not reported | Q4 2018 | |
| $1.1M | 0.24% | 0.00% | -3.5% | Q4 2023 | |
| $1.04M | 0.23% | 0.00% | -0.3% | Q4 2018 | |
| $1.04M | 0.23% | Not reported | New | Q2 2026 | |
| $1.01M | 0.22% | 0.00% | +2.8% | Q4 2023 | |
| $960K | 0.21% | 0.01% | +0.6% | Q1 2026 | |
| $953K | 0.21% | 0.00% | -1.8% | Q4 2018 | |
| $946K | 0.20% | 0.01% | New | Q2 2026 | |
| $937K | 0.20% | 0.00% | -1.4% | Q1 2024 | |
| $910K | 0.20% | 0.00% | -2.5% | Q1 2024 | |
| $910K | 0.20% | 0.00% | -2.4% | Q1 2022 | |
| $909K | 0.20% | 0.00% | -1.2% | Q4 2018 | |
| $905K | 0.20% | 0.00% | -1.7% | Q4 2018 | |
| $880K | 0.19% | Not reported | 0.0% | Q1 2020 | |
| $879K | 0.19% | 0.00% | -1.5% | Q1 2021 | |
| $864K | 0.19% | 0.00% | +0.9% | Q4 2019 | |
| $860K | 0.19% | 0.00% | -0.2% | Q1 2020 | |
| $815K | 0.18% | 0.00% | -1.7% | Q3 2025 | |
| Q1 2026Reported Apr 17, 2026165 positions | |||||
| $14M | 3.39% | Not reported | -8.8% | Q4 2018 | |
| $12.9M | 3.12% | 0.00% | -1.8% | Q4 2019 | |
| $5.97M | 1.44% | 0.00% | +1.3% | Q4 2018 | |
| $5.08M | 1.23% | 0.00% | -9.9% | Q4 2018 | |
| $3.86M | 0.93% | 0.00% | -1.2% | Q4 2018 | |
| $3.71M | 0.90% | Not reported | -15.3% | Q4 2018 | |
| $3.21M | 0.78% | 0.00% | -0.5% | Q4 2018 | |
| $3.17M | 0.77% | 0.00% | +0.7% | Q4 2018 | |
| $3.13M | 0.76% | 0.00% | -0.2% | Q4 2018 | |
| $2.96M | 0.72% | Not reported | -37.2% | Q4 2020 | |
| $2.22M | 0.54% | 0.00% | -2.3% | Q4 2018 | |
| $2.13M | 0.52% | 0.00% | +0.4% | Q4 2019 | |
| $2.1M | 0.51% | 0.00% | +0.2% | Q4 2018 | |
| $1.82M | 0.44% | 0.04% | +117.2% | Q4 2025 | |
| $1.64M | 0.40% | Not reported | +0.1% | Q4 2018 | |
| $1.64M | 0.40% | 0.22% | Not reported | Q2 2020 | |
| $1.56M | 0.38% | 0.03% | Not reported | Q1 2022 | |
| $1.43M | 0.35% | Not reported | -2.6% | Q4 2025 | |
| $1.41M | 0.34% | 0.00% | +24.6% | Q4 2019 | |
| $1.3M | 0.31% | Not reported | -3.3% | Q4 2018 | |
| $1.27M | 0.31% | 0.00% | +4.6% | Q4 2018 | |
| $1.2M | 0.29% | 0.00% | -1.9% | Q4 2018 | |
| $1.12M | 0.27% | 0.00% | -1.6% | Q4 2018 | |
| $1.1M | 0.27% | Not reported | -1.7% | Q3 2024 | |
| $1.09M | 0.26% | 0.00% | -2.2% | Q1 2025 | |
| $1.03M | 0.25% | 0.00% | +0.2% | Q4 2018 | |
| $1.01M | 0.25% | 0.00% | -0.5% | Q4 2018 | |
| $1.01M | 0.24% | 0.00% | Not reported | Q4 2018 | |
| $990K | 0.24% | 0.00% | +218.2% | Q3 2024 | |
| $975K | 0.24% | 0.00% | -2.1% | Q3 2024 | |
| $960K | 0.23% | 0.00% | -5.5% | Q2 2020 | |
| $903K | 0.22% | 0.00% | -4.7% | Q1 2022 | |
| $902K | 0.22% | Not reported | -3.3% | Q1 2020 | |
| $891K | 0.22% | 0.00% | -8.9% | Q4 2018 | |
| $877K | 0.21% | 0.00% | -2.0% | Q3 2019 | |
| $859K | 0.21% | 0.00% | -34.0% | Q4 2018 | |
| $855K | 0.21% | 0.00% | +0.2% | Q1 2024 | |
| $848K | 0.21% | 0.00% | +4.7% | Q4 2018 | |
| $840K | 0.20% | 0.00% | -3.4% | Q4 2018 | |
| $832K | 0.20% | 0.00% | +424.6% | Q3 2025 | |
| $831K | 0.20% | 0.00% | Not reported | Q1 2022 | |
| $809K | 0.20% | 0.00% | -2.2% | Q4 2018 | |
| $806K | 0.20% | 0.00% | -2.7% | Q4 2018 | |
| $801K | 0.19% | 0.00% | -4.6% | Q1 2024 | |
| $785K | 0.19% | 0.00% | -3.1% | Q3 2024 | |
| $733K | 0.18% | 0.00% | -0.7% | Q4 2019 | |
| $732K | 0.18% | 0.00% | -0.7% | Q1 2024 | |
| $731K | 0.18% | 0.00% | Not reported | Q4 2018 | |
| $726K | 0.18% | 0.00% | +1.0% | Q1 2024 | |
| $723K | 0.17% | 0.00% | +0.3% | Q1 2020 | |
| Q4 2025Reported Feb 11, 2026164 positions | |||||
| $16.4M | 3.70% | Not reported | -1.2% | Q4 2018 | |
| $14M | 3.17% | 0.00% | +8.7% | Q4 2019 | |
| $9.57M | 2.16% | 1.02% | -1.0% | Q1 2024 | |
| $6.31M | 1.43% | 0.00% | +9.2% | Q4 2018 | |
| $5.1M | 1.15% | 0.00% | +17.9% | Q4 2018 | |
| $4.81M | 1.09% | Not reported | +0.3% | Q4 2020 | |
| $4.59M | 1.04% | Not reported | -1.8% | Q4 2018 | |
| $4M | 0.90% | 0.00% | +27.3% | Q4 2018 | |
| $3.43M | 0.77% | 0.00% | -15.0% | Q4 2018 | |
| $2.65M | 0.60% | 0.00% | +2.5% | Q4 2018 | |
| $2.38M | 0.54% | 0.00% | -0.9% | Q4 2018 | |
| $2.36M | 0.53% | 0.00% | -14.7% | Q4 2018 | |
| $1.95M | 0.44% | 0.00% | +48.7% | Q4 2019 | |
| $1.82M | 0.41% | 0.00% | +32.3% | Q4 2018 | |
| $1.72M | 0.39% | Not reported | -3.4% | Q4 2018 | |
| $1.55M | 0.35% | Not reported | -1.0% | Q4 2018 | |
| $1.49M | 0.34% | 0.03% | Not reported | Q1 2022 | |
| $1.36M | 0.31% | 0.00% | +59.8% | Q4 2018 | |
| OBONEZOne Bio, Corp. | $1.34M | 0.30% | Not reported | +93.2% | Q2 2025 |
| $1.33M | 0.30% | 0.00% | +22.9% | Q4 2018 | |
| $1.32M | 0.30% | 0.00% | -5.8% | Q4 2018 | |
| $1.24M | 0.28% | Not reported | New | Q4 2025 | |
| $1.22M | 0.28% | 0.00% | -2.6% | Q4 2018 | |
| $1.16M | 0.26% | Not reported | -1.4% | Q3 2024 | |
| $1.04M | 0.24% | 0.00% | +19.3% | Q4 2019 | |
| $1.02M | 0.23% | 0.00% | +0.7% | Q4 2018 | |
| $1.02M | 0.23% | 0.00% | Not reported | Q1 2022 | |
| $994K | 0.22% | 0.00% | -25.4% | Q2 2020 | |
| $966K | 0.22% | Not reported | -1.9% | Q1 2020 | |
| $960K | 0.22% | 0.00% | +21.2% | Q3 2019 | |
| $905K | 0.20% | 0.00% | +6.3% | Q4 2018 | |
| $898K | 0.20% | 0.00% | -5.0% | Q4 2018 | |
| $880K | 0.20% | 0.00% | +31.1% | Q4 2018 | |
| $879K | 0.20% | 0.00% | -3.8% | Q4 2018 | |
| $858K | 0.19% | 0.00% | -48.7% | Q1 2022 | |
| $847K | 0.19% | 0.00% | +12.8% | Q4 2018 | |
| $832K | 0.19% | 0.00% | +12.1% | Q4 2019 | |
| $825K | 0.19% | 0.00% | +52.6% | Q1 2019 | |
| $813K | 0.18% | 0.00% | +2.0% | Q1 2022 | |
| $809K | 0.18% | 0.00% | -23.7% | Q4 2018 | |
| $804K | 0.18% | 0.02% | New | Q4 2025 | |
| $799K | 0.18% | 0.00% | -1.4% | Q4 2018 | |
| $799K | 0.18% | 0.00% | -11.5% | Q3 2025 | |
| $780K | 0.18% | 0.00% | -28.5% | Q1 2024 | |
| $779K | 0.18% | 0.00% | -5.7% | Q3 2024 | |
| $747K | 0.17% | 0.00% | -57.8% | Q1 2024 | |
| $746K | 0.17% | 0.00% | +22.1% | Q4 2018 | |
| $730K | 0.17% | 0.00% | -0.2% | Q3 2022 | |
| $726K | 0.16% | 0.00% | +64.0% | Q2 2025 | |
| $724K | 0.16% | Not reported | +16.1% | Q4 2018 | |
| Q3 2025Reported Oct 30, 2025162 positions | |||||
| $16.2M | 4.03% | Not reported | -5.5% | Q4 2018 | |
| $12.9M | 3.22% | 0.00% | -0.8% | Q4 2019 | |
| $9.45M | 2.35% | 1.03% | -45.2% | Q1 2024 | |
| $5.41M | 1.35% | 0.00% | -8.3% | Q4 2018 | |
| $4.64M | 1.16% | Not reported | -0.6% | Q4 2020 | |
| $4.63M | 1.15% | 0.00% | -3.8% | Q4 2018 | |
| $4.56M | 1.14% | Not reported | +30.0% | Q4 2018 | |
| $3.65M | 0.91% | 0.18% | -50.0% | Q4 2018 | |
| $3.13M | 0.78% | 0.00% | -4.2% | Q4 2018 | |
| $2.94M | 0.73% | 0.00% | -0.1% | Q4 2018 | |
| $2.64M | 0.66% | 0.00% | +0.9% | Q4 2018 | |
| $2.44M | 0.61% | 0.00% | +11.9% | Q4 2018 | |
| $2.32M | 0.58% | 0.00% | -2.9% | Q4 2018 | |
| $1.77M | 0.44% | Not reported | -9.3% | Q4 2018 | |
| $1.74M | 0.43% | Not reported | -5.3% | Q4 2018 | |
| $1.69M | 0.42% | 0.00% | -4.2% | Q1 2024 | |
| $1.48M | 0.37% | 0.01% | -3.2% | Q1 2022 | |
| $1.43M | 0.36% | 0.03% | Not reported | Q1 2022 | |
| $1.36M | 0.34% | 0.00% | -10.1% | Q4 2018 | |
| $1.26M | 0.31% | Not reported | -3.4% | Q3 2024 | |
| $1.25M | 0.31% | 0.00% | -1.1% | Q2 2020 | |
| $1.18M | 0.29% | 0.00% | -3.2% | Q4 2019 | |
| $1.11M | 0.28% | 0.00% | +31.3% | Q4 2018 | |
| $1.1M | 0.27% | Not reported | +2.5% | Q1 2020 | |
| $1.09M | 0.27% | 0.00% | +29.2% | Q4 2018 | |
| $1.08M | 0.27% | 0.00% | -14.1% | Q4 2018 | |
| $1.06M | 0.26% | 0.00% | +0.5% | Q4 2018 | |
| $1.03M | 0.26% | 0.00% | +0.5% | Q1 2025 | |
| $1M | 0.25% | 0.00% | -2.3% | Q4 2018 | |
| $1M | 0.25% | 0.00% | -2.8% | Q1 2024 | |
| $987K | 0.25% | 0.00% | Not reported | Q4 2018 | |
| $951K | 0.24% | 0.00% | -0.4% | Q1 2022 | |
| $951K | 0.24% | 0.00% | -2.5% | Q4 2018 | |
| $913K | 0.23% | 0.00% | -20.5% | Q1 2024 | |
| $909K | 0.23% | 0.00% | +0.7% | Q3 2023 | |
| $900K | 0.22% | 0.00% | -9.0% | Q3 2019 | |
| $899K | 0.22% | 0.00% | -1.6% | Q4 2018 | |
| $867K | 0.22% | 0.00% | New | Q3 2025 | |
| $808K | 0.20% | 0.00% | -11.6% | Q4 2018 | |
| $787K | 0.20% | 0.00% | +17.4% | Q4 2018 | |
| $782K | 0.19% | 0.00% | -11.0% | Q4 2019 | |
| $781K | 0.19% | 0.00% | -0.6% | Q4 2018 | |
| $778K | 0.19% | 0.00% | -3.1% | Q3 2024 | |
| $752K | 0.19% | 0.00% | +56.3% | Q1 2020 | |
| $750K | 0.19% | 0.00% | -1.0% | Q4 2023 | |
| $726K | 0.18% | 0.00% | -1.8% | Q1 2022 | |
| $722K | 0.18% | 0.00% | Not reported | Q1 2022 | |
| $714K | 0.18% | 0.00% | Not reported | Q3 2022 | |
| OBONEZOne Bio, Corp. | $706K | 0.18% | Not reported | +95.3% | Q2 2025 |
| $698K | 0.17% | 0.00% | Not reported | Q1 2022 | |
Premium opens every quarter this fund has filed